These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 15292526)

  • 41. The status of doping and drug use and the implications for boxing.
    Wadler GI
    Clin Sports Med; 2009 Oct; 28(4):533-43, v-vi. PubMed ID: 19819400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overview of the legal framework applicable to the marker method for the detection of human growth hormone.
    Young RR; Bielak JS; Horvitz SL
    Growth Horm IGF Res; 2009 Aug; 19(4):366-8. PubMed ID: 19608446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic use exemptions (TUEs) at the Olympic Games 1992-2012.
    Fitch KD
    Br J Sports Med; 2013 Sep; 47(13):815-8. PubMed ID: 23591601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A third generation approach to detect erythropoietin abuse in athletes.
    Sharpe K; Ashenden MJ; Schumacher YO
    Haematologica; 2006 Mar; 91(3):356-63. PubMed ID: 16503554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Athletes' knowledge and views on OTC medication.
    Mottram D; Chester N; Atkinson G; Goode D
    Int J Sports Med; 2008 Oct; 29(10):851-5. PubMed ID: 18401811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medication use by athletes at the Athens 2004 Summer Olympic Games.
    Tsitsimpikou C; Tsiokanos A; Tsarouhas K; Schamasch P; Fitch KD; Valasiadis D; Jamurtas A
    Clin J Sport Med; 2009 Jan; 19(1):33-8. PubMed ID: 19124981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antidoping program: an important factor in the promotion and protection of the integrity of sport and athlete's health.
    Mazzeo F; Monda V; Santamaria S; Nigro E; Valenzano A; Villano I; Cibelli G; Messina A; Messina G
    J Sports Med Phys Fitness; 2018; 58(7-8):1135-1145. PubMed ID: 28738670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abuse of medicines for performance enhancement in sport: why is this a problem for the pharmaceutical industry?
    Elliott S; Leishman B
    Bioanalysis; 2012 Jul; 4(13):1681-90. PubMed ID: 22831483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure and Development of the List of Prohibited Substances and Methods.
    Kinahan A; Budgett R; Mazzoni I
    Med Sport Sci; 2017; 62():39-54. PubMed ID: 28571027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories.
    Georgakopoulos C; Saugy M; Giraud S; Robinson N; Alsayrafi M
    Bioanalysis; 2012 Jul; 4(13):1549-63. PubMed ID: 22831472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein chips for high-throughput doping screening in athletes.
    Du H; Cheng J
    Expert Rev Proteomics; 2006 Feb; 3(1):111-4. PubMed ID: 16445355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Arrhythmogenic effects of illicit drugs in athletes.
    Furlanello F; Bentivegna S; Cappato R; De Ambroggi L
    Ital Heart J; 2003 Dec; 4(12):829-37. PubMed ID: 14976846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
    Zorzoli M; Pipe A; Garnier PY; Vouillamoz M; Dvorak J
    Br J Sports Med; 2014 May; 48(10):862-6. PubMed ID: 24648438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The fight against doping: today and tomorrow].
    Rieu M
    Bull Acad Natl Med; 2004; 188(6):955-71; discussion 972. PubMed ID: 15651425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmaceutical services at the Tenth Pan American Games.
    Wagner JC; Ulrich LR; McKean DC; Blankenbaker RG
    Am J Hosp Pharm; 1989 Oct; 46(10):2023-7. PubMed ID: 2479267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Doping-related problems in clinical practice].
    Villiger B; Monnat A
    Ther Umsch; 2001 Apr; 58(4):232-8. PubMed ID: 11344955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beyond reasonable doubt: catching the growth hormone cheats.
    Holt RI
    Pediatr Endocrinol Rev; 2007 Mar; 4(3):228-32. PubMed ID: 17551486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A conceptual framework for achieving performance enhancing drug compliance in sport.
    Donovan RJ; Egger G; Kapernick V; Mendoza J
    Sports Med; 2002; 32(4):269-84. PubMed ID: 11929355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug testing of athletes.
    Uzych L
    Br J Addict; 1991 Jan; 86(1):25-31. PubMed ID: 2009393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Attention to doping controls required when prescribing for athletes.
    Johnston AM
    Chest; 2006 Oct; 130(4):1283-4. PubMed ID: 17035475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.